Abstract
Objective:
To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines.
Design:
The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9±14.9 years (range 20–90).
Results:
The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20–29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20–29 years to 74.6% in those aged 60–69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.
Conclusions:
The prevalence of the MS in the adult Turkish population is very high, especially in women. Our findings have important implications for public health in Turkey.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abate N (2000). Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabet Complicat 14, 154–174.
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003). Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diab Res Clin Pract 61, 29–37.
Chuang SY, Chen CH, Chou P (2004). Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 67, 611–620.
Das UND (2002). Metabolic syndrome X is common in South Asians, but why and how? Nutrition 18, 774–776.
Duc Son LNT, Kunii D, Hung NT, Sakai T, Yamamoto S (2005). The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabet Res Clin Pract 67, 243–250.
Enkhmaaa B, Shiwakua K, Anuurada E, Nogib A, Kitajimaa K, Yamasakia M et al. (2005). Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 352, 105–113.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
Ford ES, Giles WH, Dietz WH (2002). Prevalence of metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
Grundy SM (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 83, 25F–29F.
Grundy SM, Abate N, Chandalia M (2002). Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med 113, 25S–29S.
Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K (2004). Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97, 257–261.
Hatemi H, Yumuk VD, Turan N, Arık N (2003). Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord 1, 285–290.
Ilerigelen B, Kabakci G, Koylan N, Kozan O, Buyukozturk K (2005). Coexisting dyslipidemia in hypertensive patients (Abstract). Atherosclerosis 6 (Suppl), 156.
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet Care 24, 683–689.
Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JCY et al. (2004). Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabet Obes Metab 6, 353–362.
Jensen T, Truong Q, Frandsen M, Dinesen B, Stender S (2002). Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients. Diabet Care 25, 1914–1918.
Kim ES, Han SM, Kim YI, Song KH, Kim MS, Kim WB et al. (2004). Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 21, 1141–1143.
Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ (2004). Prevalence of the metabolic syndrome among 40 698 Korean metropolitan subjects. Diabet Res Clin Pract 65, 143–149.
Mahley RWW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V et al. (1995). Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36, 839–859.
Onat A, Sansoy V (2002). Metabolic syndrome, major culprit of coronary disease among turks: its prevalence and impact on coronary risk. Arch Turk Soc Cardiol 30, 8–15.
Onat A, Yildirim B, Cetinkaya A, Aksu H, Keles I, Uslu N et al. (1999a). Indices of obesity and central obesity in Turkish Adults: distinct rise in obesity in 1990–98 more pronounced among men. Arch Turk Soc Cardiol 27, 209–217.
Onat A, Yıldırım AB, Uslu N, Gürbüz N, Keles I, Çetinkaya A et al. (1999b). Plasma lipoproteins and apolipoproteins in Turkish adults: overall levels, associations with other risk parameters and HDL's role as a marker of coronary risk in women. Arch Turk Soc Cardiol 27, 72–79.
Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L et al. (2004). Prevalence of the metabolic syndrome in a Turkish adult population. Diabet Nutr Metab 17, 230–234.
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V et al. (2003). Metabolic syndrome in urban Asian Indian adults – a population study using modified ATP III criteria. Diabet Res Clin Pract 60, 199–204.
Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M (2006). Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 6, 92.
Satman I, Yilmaz MT, Sengul A, Salman S, Salman F, Uygur S et al. (2002). Population based study of diabetes and risk characteristics in Turkey. Results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabet Care 25, 1551–1556.
Thomas GN, Ho SY, Janus ED, Lam KSL, Hedley AJ, Lam TH (2005). The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabet Res Clin Practice 67, 251–257.
Thomas GN, Tomlinson B, Chan JCN, Lee ZSK, Cockram CS, Critchley JAJH (2000). An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hypertens 13, 745–752.
Uzunlulu M, Oguz A, Tigen K (2005). High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected? Anadolu Kardiyol Derg 5, 268–270.
Acknowledgements
This study was supported by an unrestricted grant from the Abdi İbrahim Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: A Abaci.
Contributors: OK, AO, AA, CE, ZO, AT and SC participated in the design and conduct of the study. All the authors contributed to the writing and revision of the paper for which AA is guarantor. The order of the contributors was agreed among the investigators, and the first listed contributor made the greatest contribution to the paper, and then in decreasing order.
Rights and permissions
About this article
Cite this article
Kozan, O., Oguz, A., Abaci, A. et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 61, 548–553 (2007). https://doi.org/10.1038/sj.ejcn.1602554
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602554
Keywords
This article is cited by
-
Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: a cross-sectional study in Syria
BMC Urology (2023)
-
Profile of hypertension in Turkey: from prevalence to patient awareness and compliance with therapy, and a focus on reasons of increase in hypertension among youths
Journal of Human Hypertension (2022)
-
Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program
Journal of Diabetes & Metabolic Disorders (2021)
-
What is the role of metabolic syndrome and obesity for postoperative atrial fibrillation after coronary bypass grafting?
BMC Cardiovascular Disorders (2019)
-
Genetic polymorphisms of the SHBG gene can be the effect on SHBG and HDL-cholesterol levels in Coronary Heart Disease: a case–control study
Molecular Biology Reports (2019)